News

Investors Alert: DENTSPLY SIRONA Inc. Faces Class Action Deadline

Investors Alert: DENTSPLY SIRONA Inc. Faces Class Action Deadline

Understanding the Class Action Lawsuit for DENTSPLY SIRONA Inc.

Investors in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) are being reminded of an important deadline related to a securities fraud class action lawsuit. Bernstein Liebhard LLP, a respected investment law firm, has highlighted the upcoming deadline for shareholders who acquired shares between December 1, 2022, and November 6, 2024.

Key Considerations for DENTSPLY SIRONA Inc. Investors

If you owned shares during this period, you might have critical rights worth discussing. The investor rights law firm emphasizes the importance of gathering information regarding your legal rights and options. If you believe you suffered financial losses due to potential misrepresentations by DENTSPLY, it’s advisable to stay informed and possibly take action.

What Led to the Lawsuit?

The lawsuit alleges that DENTSPLY misled investors about the growth and performance of its aligner solution business, specifically its direct-to-consumer product, Byte. Investors expressed concern over the company's ability to convert potential customers into paying patients effectively, which led to significant allegations against DENTSPLY's management.

Seeking Lead Plaintiffs

For those interested in taking a more active role, there is an opportunity to become a lead plaintiff in this case. However, it's essential to note that filing as a lead plaintiff must be done by a specific deadline, and you do not have to take on this role to participate in any recovery efforts.

Representation and Fees

One reassuring aspect for shareholders is that representation in these matters typically operates on a contingency fee basis. This means that investors bear no upfront costs for legal fees or expenses unless there is a successful outcome in the litigation.

Bernstein Liebhard LLP's Reputation

Having secured over $3.5 billion for clients since its inception in 1993, Bernstein Liebhard LLP has established a strong reputation in the field of investor rights. They are known for representing both individual shareholders and larger institutional investors, highlighting their experience in managing complex securities class actions.

Contact Information for DENTSPLY SIRONA Inc. Investors

Investors who wish to discuss their situation can reach out directly to Peter Allocco, the Investor Relations Manager at Bernstein Liebhard LLP, at (212) 951-2030. He is available to provide information and assist interested parties in understanding their rights regarding the ongoing litigation.

Frequently Asked Questions

What is the deadline for the DENTSPLY SIRONA Inc. class action?

The deadline to file as a lead plaintiff is January 27, 2025.

Who can participate in the lawsuit?

Anyone who purchased shares of DENTSPLY SIRONA Inc. between December 1, 2022, and November 6, 2024, can discuss their rights.

What does being a lead plaintiff involve?

A lead plaintiff acts on behalf of other shareholders in the case and directs the litigation.

Are there any costs for joining the lawsuit?

There are no fees or expenses for shareholders unless there is a successful recovery in the case.

How can I get more information on my rights?

Contact Peter Allocco at Bernstein Liebhard LLP for detailed information and guidance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zhihu Inc.'s Share Units Grant: Incentives and Performance Insights

Updated Category News Views 54

Zhihu Inc. Issues Restricted Share Units to Enhance Employee Incentives Zhihu Inc. (NYSE:ZH), a prominent online content community, recently disclosed an important development concerning its employee incentive programs. The company has issued restricted share units, aligning with its 2022 Share Incentive Plan, as documented in a Form 6-K filed with the Securities and...

Continue Reading
How to Make the Cash in Your Investment Portfolio Work Harder

Updated Category Investing Views 114

Ask most investors where their money sits and they will describe their equity positions in detail. Ask about the cash and the answer gets vague fast. That cash is usually the least examined line on the whole balance sheet. It is also, for a lot of people, a meaningful share of net worth sitting somewhere that was chosen years ago and never revisited. Cash is not the...

Continue Reading
Novo Nordisk's amycretin Moves to Phase 3 for Weight Management

Updated Category News Views 546

Advancements in Obesity Treatment by Novo Nordisk In the quest for effective obesity treatments, Novo Nordisk has made significant strides with their investigational drug, amycretin. This novel therapy aims to assist individuals struggling with obesity by targeting appetite regulation. Recent results from early-phase clinical trials have been published, showcasing...

Continue Reading
Shell's Challenge in Finalizing the German Refinery Deal

Updated Category News Views 133

Shell Faces Challenges in Selling the Schwedt Refinery Shell is currently encountering significant delays in its efforts to sell a stake in the Schwedt refinery. A number of pending lawsuits from third parties are largely responsible for this situation, placing a long-anticipated divestment on hold. The Schwedt refinery is vital for fuel supply, and this contentious sale...

Continue Reading
Stock Images Market Poised for Growth with Increasing Demand

Updated Category News Views 319

Exploring the Growth of the Stock Images Market The stock images market is experiencing a promising expansion, with estimates that it will grow by USD 1.28 billion between 2025 and 2029. This growth is driven by the increasing need for high-quality imagery for various applications, fostering a continually evolving market landscape. Market Segmentation Insights...

Continue Reading